Aquatic Capital Management LLC Argenx Se Transaction History

Aquatic Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $3.73 Million - $4.31 Million	10,440 New	10,440 $4.11 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $5.73 Million - $8.51 Million	15,520 New	15,520 $7.63 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $768,729 - $928,395	2,300 New	2,300 $857,000
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $1.34 Million - $1.54 Million	3,900 New	3,900 $1.38 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $50,890 - $70,212	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $54,402 - $70,606	200 New	200 $70,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.